Clinical Trial Update: Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the use of statins in patients with clonal cytopenia of undetermined significance (CCUS) and myelodysplastic syndromes (MDS)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clonal Cytopenia of Undetermined Significance
• Myelodysplastic Syndromes

Drugs mentioned

• Statins

Snippet

Sponsor: Washington University School of Medicine | Conditions: Clonal Cytopenia of Undetermined Significance, Myelodysplastic Syndromes | Phase 2 | Status: RECRUITING